ACADIA Pharmaceuticals
ACAD
$17.05
Share price
-0.18%
Change (1 day)
-19.58%
Change (1 year)
Categories
Operating Margin for ACADIA Pharmaceuticals (ACAD)
Operating Margin as of May 2024 (TTM): -19.22%
According to ACADIA Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -19.22%. At the end of 2022 the company had an Operating Margin of -41.27%.
Operating Margin history for ACADIA Pharmaceuticals from 2003 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -41.27% | 19.26% |
| 2021 | -34.60% | -45.6% |
| 2020 | -63.60% | -7.99% |
| 2019 | -69.12% | -36.58% |
| 2018 | -108.99% | -52.78% |
| 2017 | -230.81% | -85.19% |
| 2016 | -1,558.20% | -99.42% |
| 2015 | -269,037.70% | 249.12% |
| 2014 | -77,062.50% | 2225.2% |
| 2013 | -3,314.24% | 680.04% |
| 2012 | -424.88% | -61.57% |
| 2011 | -1,105.56% | -3186.19% |
| 2010 | 35.82% | -105.04% |
| 2009 | -710.55% | -83.13% |
| 2008 | -4,212.45% | 407.95% |
| 2007 | -829.31% | 37.5% |
| 2006 | -603.15% | 84.56% |
| 2005 | -326.81% | -42.34% |
| 2004 | -566.76% | 204.35% |
| 2003 | -186.22% | -7.44% |
| 2002 | -201.19% | -51.09% |
| 2001 | -411.39% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -219.04% | 🇺🇸 USA |
 Pfizer PFE | 34.61% | -280.07% | 🇺🇸 USA |
 Eli Lilly LLY | 24.66% | -228.30% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 19.24% | -200.10% | 🇺🇸 USA |
 Vanda Pharmaceuticals VNDA | 6.23% | -132.41% | 🇺🇸 USA |
 Adamas Pharmaceuticals
ADMS | -43.80% | 127.90% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.